Overview
Top Medical Research Studies
The results were promising. Mice that received the vitamin D3 supplement showed significantly lower viral levels in their lungs compared to mice that were fed a standard diet. Furthermore, we noticed a decrease in certain pro-inflammatory cytokines, namely IL-5 and IFN-γ, which are involved in the body's inflammatory response to infection. Importantly, we found that the anti-inflammatory cytokines did not see a significant increase.
These findings suggest that 25(OH)D can help to suppress excessive inflammatory responses and may reduce both the replication of the virus and the overall severity of influenza in this mouse model. It opens the door to further exploration on vitamin D3's role in combating influenza in humans.
Our findings showed that vitamin D supplementation was associated with a significant reduction in the risk of influenza infections. Specifically, we noted a 22% decrease in risk, with our calculations presenting a risk ratio of 0.78. Notably, there was little variability in outcomes among the included studies, suggesting that the results were quite consistent.
Additionally, our research indicated no signs of publication bias, adding credibility to our findings. This suggests that incorporating vitamin D supplementation into preventive strategies for influenza could be beneficial. Overall, vitamin D stands out as a promising option for reducing the risk of influenza infections, reinforcing the idea that it plays a crucial role in bolstering our immune defenses.
The results were revealing. Initially, we found that the occurrence of influenza A was significantly lower among students taking vitamin D3 compared to those on the placebo during the first month. Specifically, just 1.4% of the vitamin D3 group got sick, compared to 8.1% in the placebo group—a clear early benefit.
However, as the study continued into the second month, the trend shifted. We observed that the vitamin D3 group began to experience more influenza A cases, catching up with the placebo group. Ultimately, there was no significant overall effect of vitamin D3 in reducing influenza A incidence throughout the entire study duration.
While it's exciting to see potential benefits early on, the findings indicate that vitamin D3 supplementation did not consistently lower the overall risk of influenza A during this pandemic.
Most Useful Reviews
Medical Researches
- All Researches
Our findings indicate that vitamin D supplementation does not significantly reduce the overall rates of acute respiratory tract infections among healthy children. We observed no notable differences in infection rates between those receiving vitamin D and those given a placebo. This suggests that for general respiratory infections, the benefits of vitamin D supplementation might not be as impactful as once thought.
However, there was a noteworthy reduction in Influenza A cases among the children who received higher doses of vitamin D compared to those receiving lower doses. This finding could signal potential benefits for preventing this specific virus, though we must also note that only a couple of studies reported side effects, which were generally minimal.
Overall, while vitamin D shows some promise in reducing Influenza A cases, it does not appear to enhance protection against acute respiratory tract infections as a whole in the healthy pediatric population.
The results were promising. Mice that received the vitamin D3 supplement showed significantly lower viral levels in their lungs compared to mice that were fed a standard diet. Furthermore, we noticed a decrease in certain pro-inflammatory cytokines, namely IL-5 and IFN-γ, which are involved in the body's inflammatory response to infection. Importantly, we found that the anti-inflammatory cytokines did not see a significant increase.
These findings suggest that 25(OH)D can help to suppress excessive inflammatory responses and may reduce both the replication of the virus and the overall severity of influenza in this mouse model. It opens the door to further exploration on vitamin D3's role in combating influenza in humans.
Our findings revealed that IAV reduces the effectiveness of autophagy, a crucial process that helps cells dispose of damaged components. This disruption in autophagy increases cell death, leading to more severe inflammation and tissue damage during infection.
Importantly, we found that Vitamin D3 can counteract this negative effect by restoring autophagic activity. By boosting the expression of specific proteins involved in autophagy, Vitamin D3 helps reduce apoptosis, allowing the cells to survive better during IAV infection. This suggests that Vitamin D3 may play a valuable role in protecting our cells from influenza-related injury.
Importantly, we found that the activation of the vitamin D3 receptor in skin cells played a crucial role in this enhanced response. The application of Oxarol led to the higher expression of thymic stromal lymphopoietin (TSLP), a molecule essential for the immune process. By using experiments with recombinant TSLP and specific cell-type deletions, we clarified that certain immune cells were pivotal in these positive reactions triggered by Oxarol.
Overall, our results indicate that vitamin D3 can significantly improve the body's response to influenza vaccines, serving as a promising new adjuvant. This could pave the way for safer and more effective vaccination strategies in the future.
The findings were promising, showing that a higher vitamin D3 status was associated with a better serological response to the vaccine. Specifically, 80% of the participants responded positively against at least one flu strain. It was noteworthy that all patients in the upper quartile of vitamin D3 levels had a strong immune response, suggesting a clear connection between adequate vitamin D3 levels and vaccine effectiveness.
However, we also noted that other factors like age, race, and chemotherapy status did not significantly impact how well participants responded to the vaccine. This indicates that vitamin D3 levels might play a crucial role in bolstering the immune response to influenza vaccination, particularly in this specific patient group.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Influenza, commonly referred to as the flu, is a highly contagious viral infection that primarily affects the respiratory system. Caused by influenza viruses, it can lead to mild to severe illness and can result in hospitalization or even death, particularly in vulnerable populations such as the elderly, young children, and individuals with certain health conditions. Symptoms typically include fever, chills, cough, sore throat, body aches, headaches, and fatigue. It's important to note that while many people refer to common colds as the flu, the flu is generally more severe and lasts longer.
Preventing influenza is possible through vaccination, which is recommended annually as the viruses can change from year to year. Other preventive measures include practicing good hygiene, such as regular hand washing and avoiding close contact with infected individuals. If someone does contract the flu, antiviral medications may be prescribed by a healthcare provider, particularly if the treatment begins within the first few days of illness. Understanding the nature of influenza and the importance of preventive measures can help individuals protect themselves and their communities during flu season.
Vitamin D is a fat-soluble vitamin that's essential for maintaining healthy bones and teeth, supporting immune system function, and facilitating normal cell growth and development. It plays a crucial role in calcium absorption in the gut, which is vital for bone health. Unlike most vitamins, our bodies can produce Vitamin D when exposed to sunlight, specifically UVB rays, which is why it’s often referred to as the "sunshine vitamin." However, depending on your geographical location, lifestyle, and skin type, getting sufficient Vitamin D from the sun alone can be challenging, particularly during the winter months.
In addition to sunlight, Vitamin D can be obtained from certain foods such as fatty fish (like salmon and mackerel), fish liver oils, and fortified foods like milk and cereals. Some individuals may also consider supplements, especially if they're at risk for deficiency. Insufficient vitamin D levels are linked to various health issues, including rickets in children, osteomalacia in adults, and even an increased risk of chronic diseases. Regularly checking your vitamin D levels and consulting with a healthcare professional can help ensure you're meeting your needs for optimal health.
Vitamin D has garnered attention for its potential role in immune function, particularly in relation to respiratory infections, including influenza. Some studies suggest that adequate levels of vitamin D may contribute to a stronger immune response, potentially reducing the risk of contracting viral infections or mitigating their severity. The vitamin is believed to play a role in the production of antimicrobial peptides and modulating the immune system, which could be beneficial during flu season.
However, the evidence is not conclusive, and while a deficiency in vitamin D is linked to increased susceptibility to infections, more research is needed to establish a direct cause-and-effect relationship between vitamin D supplementation and influenza prevention or treatment. It's always best to consult with a healthcare provider before starting any new supplementation, especially in the context of managing illnesses. Ultimately, maintaining overall health through a balanced diet, proper hygiene, and vaccinations remain key strategies for flu prevention.
Based on user reviews, individuals taking Vitamin D for influenza typically report seeing improvements in their health and immunity fairly quickly, often within a few days to weeks of consistent use. Many users indicate that they notice a significant enhancement in their immune response and a reduction in illnesses, including influenza, once they begin taking higher doses, like 5000 IU daily. For instance, one user noted, "I’ve been taking vitamin D regularly to help prevent severe respiratory infections, including colds and influenza" (Read Review). Another user claimed they "have remained healthy during influenza season" since starting their supplementation (Read Review).
Moreover, users mention that taking Vitamin D not only helps in preventing influenza but also aids in recovery when infections are present. Reviewers frequently cite that they experience overall health improvements and enhanced mood as a result of their regimen. One user even pointed out that their family began taking the supplement after witnessing its positive effects during a time when others were falling ill (Read Review). However, exact timelines for noticing changes can vary depending on factors like dosage and individual health conditions.
Research indicates that vitamin D supplementation may offer benefits for preventing influenza, particularly in vulnerable populations. A systematic review highlighted that high-dose vitamin D significantly reduced the incidence of acute respiratory infections, including influenza, by about 40% among care home residents [13]. Additionally, studies exploring vitamin D's role in immune function illustrated that adequate levels could enhance resistance to influenza viruses, as shown in both animal models and human trials [12]. For instance, vitamin D supplementation in children was linked to reduced odds of experiencing influenza symptoms by approximately 57% when doses exceeded 1,000 IU daily [3].
However, it’s essential to note that not all studies have shown consistent benefits, particularly among healthy children or adults [4]. In certain trials, vitamin D did not lead to significant differences in infection rates compared to placebo groups, suggesting variable outcomes based on dosage, timing, and individual immune responses [1]. While the potential for vitamin D as a preventive measure against influenza is promising, ongoing research is necessary to clarify its effectiveness across different demographics and health conditions.
Users have reported a variety of improvements in their health and immune function associated with Vitamin D supplementation, particularly in relation to influenza and respiratory infections. Many individuals noted a significant reduction in their incidence of illness, with some stating that, since starting or increasing their Vitamin D intake to 5000 IU or more, they rarely fall ill, even during peak infection seasons. For instance, one user shared that after taking these high-potency tablets, their "mood and immune response have dramatically improved" and they "rarely fall ill, unlike my colleagues" (Read Review). In another instance, a user mentioned being the only member of their family to avoid illness while others succumbed to influenza (Read Review).
Additionally, users report not only preventative benefits but also a swifter recovery from illnesses when Vitamin D is taken. Reviewers frequently echo sentiments that it aids in bolstering overall health and contributes positively to mood. Comments such as "I feel fantastic" after completing a vitamin regimen emphasize the perceived advantages beyond just immunity (Read Review). However, it is essential to note that individual experiences can vary widely based on factors like dosage, initial health status, and consistent intake.
Based on user reviews, many individuals report positive outcomes when combining Vitamin D with other supplements to boost immunity against influenza. One user mentioned that they successfully avoided illness while their family succumbed to both coronavirus and influenza, crediting their health to taking Vitamin D alongside liposomal vitamin C (Read Review). This highlights a common theme among reviewers who suggest that a multi-supplement approach could enhance overall immunity and provide additional protection during outbreaks.
Additionally, some users emphasize the significance of taking Vitamin D at higher doses—between 5000 IU and 20,000 IU—especially during cold and flu season, sometimes alongside other supplements like Vitamin A for optimal results (Read Review). Others echoed similar sentiments about increasing Vitamin D intake in conjunction with dietary changes for better absorption during periods of illness (Read Review). Overall, it seems that users are not just relying on Vitamin D alone but are incorporating it into a broader health regimen to effectively combat viral infections, including influenza.
According to recent research, the optimal dose of Vitamin D for potentially treating and preventing influenza varies, but doses greater than 1,000 IU daily have shown significant results. In one notable study involving young children under five, supplementation at doses above 1,000 IU reduced the chance of influenza symptoms by approximately 57% compared to standard doses or placebo [3]. Additionally, another systematic review of high-dose Vitamin D3 supplementation indicated that such doses significantly lowered the incidence rate of acute respiratory infections, including influenza, particularly among vulnerable populations such as care home residents [13].
While high doses of Vitamin D3, such as the 5,000 IU taken by healthcare workers in one study, also showed a reduction in the likelihood of influenza-like illnesses, it’s essential to remain cautious since the effectiveness can depend on individual health conditions [14]. Overall, while higher doses seem promising, particularly in specific populations, the data suggests that Vitamin D’s role as a preventive measure against influenza warrants further exploration to validate the ideal dosage and its mechanisms fully.
Specifically, one trial revealed that the incidence rate of these infections dropped significantly with Vitamin D supplementation, showing a notable improvement in health outcomes. On the other hand, while other studies explored various supplement options such as vitamins, minerals, and probiotics, most did not yield significant benefits, highlighting the uniqueness of Vitamin D's positive effect in this context.
Our findings emphasize the potential of Vitamin D3 as a valuable intervention, especially alongside standard infection control practices. Nevertheless, ongoing research is necessary to confirm these encouraging results and further understand how Vitamin D can be integrated into preventative health strategies for respiratory infections in care homes.
In this study, they found that when the mothers were vitamin D deficient, their offspring showed reduced immune cell development. By the time the researchers tested the mice against H1N1 influenza, those with lower vitamin D levels were more susceptible to the virus. This highlighted a significant link between the vitamin D status during development and the strength of the immune response in adulthood.
Interestingly, treating the vitamin D deficient mice with vitamin D helped restore some VDR expression in their immune cells and improved their resistance to the H1N1 infection. This suggests that ensuring adequate vitamin D levels during critical developmental periods could have lasting effects on our immune systems.
Overall, the study affirms that vitamin D plays a vital role in immune health, particularly in our ability to tackle viral infections like influenza.
Our findings revealed that high-dose vitamin D did not have a significant impact on the overall incidence of upper respiratory infections. However, we discovered promising results specifically regarding influenza and related symptoms. Vitamin D supplementation above 1,000 IU daily led to a notable reduction in the odds of experiencing influenza or cold symptoms by approximately 57%. Additionally, reductions in cough and fever incidence were observed, although the confidence in these results was lower.
While the evidence indicates some potential benefits of vitamin D for specific illnesses, it's crucial to interpret these findings cautiously. No meaningful improvements were found in other areas, such as bronchitis or hospitalizations. Further research is necessary to fully understand the benefits of vitamin D in combating influenza in children.
Our findings indicate that vitamin D supplementation does not significantly reduce the overall rates of acute respiratory tract infections among healthy children. We observed no notable differences in infection rates between those receiving vitamin D and those given a placebo. This suggests that for general respiratory infections, the benefits of vitamin D supplementation might not be as impactful as once thought.
However, there was a noteworthy reduction in Influenza A cases among the children who received higher doses of vitamin D compared to those receiving lower doses. This finding could signal potential benefits for preventing this specific virus, though we must also note that only a couple of studies reported side effects, which were generally minimal.
Overall, while vitamin D shows some promise in reducing Influenza A cases, it does not appear to enhance protection against acute respiratory tract infections as a whole in the healthy pediatric population.
Our findings revealed that those taking vitamin D3 experienced a lower rate of ILIs. Specifically, there was a significant decrease in non-COVID-19 ILIs among those who supplemented with vitamin D3, suggesting that this vitamin may bolster respiratory health in high-risk environments.
However, when it came to COVID-19-related ILIs, we did not find a statistically significant difference between the two groups. This means that while vitamin D3 may help with certain respiratory illnesses, its effectiveness against COVID-19 specifically remains unclear. Overall, daily vitamin D3 supplementation can be beneficial in reducing flu-like symptoms in healthcare settings.
References
- Arora J, Froelich NE, Tang M, Weaver V, Paulson RF, et al. Developmental Vitamin D Deficiency and the Vitamin D Receptor Control Hematopoiesis. J Immunol. 2024;213:1479. doi:10.4049/jimmunol.2400292
- Willcox ML, Lavu D, Yousaf U, Dalton S, Roberts N, et al. The effectiveness of interventions to reduce the transmission of acute respiratory infections in care homes: a systematic review. J Public Health (Oxf). 2024;46:551. doi:10.1093/pubmed/fdae178
- Carboo JA, Dolman-Macleod RC, Malan L, Lombard MJ. High-dose oral vitamin D supplementation for prevention of infections in children aged 0 to 59 months: a systematic review and meta-analysis. Nutr Rev. 2024;82:579. doi:10.1093/nutrit/nuad082
- Fang Q, Wu Y, Lu J, Zheng H. A meta-analysis of the association between vitamin D supplementation and the risk of acute respiratory tract infection in the healthy pediatric group. Front Nutr. 2023;10:1188958. doi:10.3389/fnut.2023.1188958
- Liao S, Huang Y, Zhang J, Xiong Q, Chi M, et al. Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus and Staphylococcus aureus infections. Respir Res. 2023;24:175. doi:10.1186/s12931-023-02477-4
- Park JH, Lee Y, Choi M, Park E. The Role of Some Vitamins in Respiratory-related Viral Infections: A Narrative Review. Clin Nutr Res. 2023;12:77. doi:10.7762/cnr.2023.12.1.77
- van Helmond N, Brobyn TL, LaRiccia PJ, Cafaro T, Hunter K, et al. Vitamin D3 Supplementation at 5000 IU Daily for the Prevention of Influenza-like Illness in Healthcare Workers: A Pragmatic Randomized Clinical Trial. Nutrients. 2022;15. doi:10.3390/nu15010180
- Arora J, Patel DR, Nicol MJ, Field CJ, Restori KH, et al. Vitamin D and the Ability to Produce 1,25(OH)D Are Critical for Protection from Viral Infection of the Lungs. Nutrients. 2022;14. doi:10.3390/nu14153061
- Huang YN, Chi H, Chiu NC, Huang CY, Li ST, et al. A randomized trial of vitamin D supplementation to prevent seasonal influenza and enterovirus infection in children. J Microbiol Immunol Infect. 2022;55:803. doi:10.1016/j.jmii.2022.01.003
- Zhu Z, Zhu X, Gu L, Zhan Y, Chen L, et al. Association Between Vitamin D and Influenza: Meta-Analysis and Systematic Review of Randomized Controlled Trials. Front Nutr. 2021;8:799709. doi:10.3389/fnut.2021.799709
- Godan Hauptman A, Lukić-Grlić A, Vraneš J, Milošević M, Gagro A. The effect of standard-dose wintertime vitamin D supplementation on influenza infection in immunized nursing home elderly residents. Croat Med J. 2021;62:495.
- Arora J, Froelich NE, Tang M, Weaver V, Paulson RF, et al. Developmental Vitamin D Deficiency and the Vitamin D Receptor Control Hematopoiesis. J Immunol. 2024;213:1479. doi:10.4049/jimmunol.2400292
- Willcox ML, Lavu D, Yousaf U, Dalton S, Roberts N, et al. The effectiveness of interventions to reduce the transmission of acute respiratory infections in care homes: a systematic review. J Public Health (Oxf). 2024;46:551. doi:10.1093/pubmed/fdae178
- van Helmond N, Brobyn TL, LaRiccia PJ, Cafaro T, Hunter K, et al. Vitamin D3 Supplementation at 5000 IU Daily for the Prevention of Influenza-like Illness in Healthcare Workers: A Pragmatic Randomized Clinical Trial. Nutrients. 2022;15. doi:10.3390/nu15010180
- Hayashi H, Okamatsu M, Ogasawara H, Tsugawa N, Isoda N, et al. Oral Supplementation of the Vitamin D Metabolite 25(OH)D Against Influenza Virus Infection in Mice. Nutrients. 2020;12. doi:10.3390/nu12072000
- Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12. doi:10.3390/nu12040988
- Godbole NM, Sinha RA, Tiwari S, Pawar SD, Dhole TN. Analysis of influenza virus-induced perturbation in autophagic flux and its modulation during Vitamin D3 mediated anti-apoptotic signaling. Virus Res. 2020;282:197936. doi:10.1016/j.virusres.2020.197936
- Sato R, Makino-Okamura C, Lin Q, Wang M, Shoemaker JE, et al. Repurposing the psoriasis drug Oxarol to an ointment adjuvant for the influenza vaccine. Int Immunol. 2020;32:499. doi:10.1093/intimm/dxaa012
- Goncalves-Mendes N, Talvas J, Dualé C, Guttmann A, Corbin V, et al. Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Front Immunol. 2019;10:65. doi:10.3389/fimmu.2019.00065
- Gui B, Chen Q, Hu C, Zhu C, He G. Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice. Virol J. 2017;14:10. doi:10.1186/s12985-017-0683-y
- Urashima M, Mezawa H, Noya M, Camargo CA. Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: a randomized controlled trial. Food Funct. 2014;5:2365. doi:10.1039/c4fo00371c
- Khare D, Godbole NM, Pawar SD, Mohan V, Pandey G, et al. Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells. Eur J Nutr. 2013;52:1405. doi:10.1007/s00394-012-0449-7
- Chadha MK, Fakih M, Muindi J, Tian L, Mashtare T, et al. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate. 2011;71:368. doi:10.1002/pros.21250
